Будь ласка, використовуйте цей ідентифікатор, щоб цитувати або посилатися на цей матеріал: http://ir.librarynmu.com/handle/123456789/13726
Повний запис метаданих
Поле DCЗначенняМова
dc.contributor.authorBurlaka, I.-
dc.contributor.authorMityuryayeva, I.-
dc.contributor.authorSevastiian, O.-
dc.contributor.authorKachula, I.-
dc.date.accessioned2024-12-12T12:34:49Z-
dc.date.available2024-12-12T12:34:49Z-
dc.date.issued2024-
dc.identifier.issnDOI: 10.1177/2333794X241276356-
dc.identifier.urihttp://ir.librarynmu.com/handle/123456789/13726-
dc.description.abstractMorphea, is a chronic inflammatory disease of the dermis and subcutaneous tissue. Research has indicated a connection between morphea and Type I Diabetes (T1D). COVID-19 can cause autoimmune diseases like scleroderma, T1D, systemic lupus erythematosus, and others. A 12-year-old girl with type 1 diabetes who was on insulin therapy was brought into the clinic for a metabolic evaluation. The patient had induration, skin hardness, and cutaneous erythema upon inspection. The onset of T1D was following a mild COVID-19 infection. Signs of morphea merged 3months after the onset of T1D. Known as “long-term COVID,” this sickness phase that follows the acute stage of COVID-19 is most likely the result of autoimmune activation. As this patient under evaluation reveals, COVID-19 has been demonstrated in the literature to cause the production of autoantibodies and to either cause or worsen autoimmune disorders in people who have a genetic susceptibility.uk_UA
dc.language.isoenuk_UA
dc.publisherGlobal Pediatric Healthuk_UA
dc.subjectmorphea, type 1 diabetes mellitus, Covid-19, children, co-existinguk_UA
dc.titleOnset of Type I Diabetes Followed by Scleroderma Syndrome in a Child After the COVID-19: A Case Reportuk_UA
dc.typeArticleuk_UA
Розташовується у зібраннях:Наукові публікації кафедри педіатрії №4

Файли цього матеріалу:
Файл Опис РозмірФормат 
Onset of Type I Diabetes Followed by Scleroderma Syndrome in a Child After the COVID-19.pdf220,93 kBAdobe PDFПереглянути/Відкрити


Усі матеріали в архіві електронних ресурсів захищені авторським правом, всі права збережені.